Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Brett Case

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Science (New York, N.Y.)|September 10, 2020
De novo design of picomolar SARS-CoV-2 miniprotein inhibitorsLongxing Cao, Inna Goreshnik, Brian Coventry, et al.
Nature Communications|June 27, 2026
Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted miceChieh-Yu Liang, Suzanne M Scheaffer, James Brett Case, et al.
Cell Reports|March 18, 2022
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprintingBlake M Hauser, Maya Sangesland, Kerri J St Denis, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in miceJames Brett Case, Rita E Chen, Longxing Cao, et al.
Nature|November 19, 2020
LDLRAD3 is a receptor for Venezuelan equine encephalitis virusHongming Ma, Arthur S Kim, Natasha M Kafai, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaquesAhmed O Hassan, Friederike Feldmann, Haiyan Zhao, et al.
Cell Reports|October 16, 2021
Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBDJohn M Errico, Haiyan Zhao, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young Do Kwon, Jason Gorman, et al.
Cell Reports. Medicine|March 23, 2021
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaquesAhmed O Hassan, Friederike Feldmann, Haiyan Zhao, et al.
Cell Reports. Medicine|January 31, 2026
An intranasal adenoviral-vectored vaccine protects against highly pathogenic avian influenza H5N1 in naive and antigen-experienced animalsBaoling Ying, Kelly Pyles, Tamarand L Darling, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Science (New York, N.Y.)|September 10, 2020
De novo design of picomolar SARS-CoV-2 miniprotein inhibitorsLongxing Cao, Inna Goreshnik, Brian Coventry, et al.
Nature Communications|June 27, 2026
Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted miceChieh-Yu Liang, Suzanne M Scheaffer, James Brett Case, et al.
Cell Reports|March 18, 2022
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprintingBlake M Hauser, Maya Sangesland, Kerri J St Denis, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in miceJames Brett Case, Rita E Chen, Longxing Cao, et al.
Nature|November 19, 2020
LDLRAD3 is a receptor for Venezuelan equine encephalitis virusHongming Ma, Arthur S Kim, Natasha M Kafai, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaquesAhmed O Hassan, Friederike Feldmann, Haiyan Zhao, et al.
Cell Reports|October 16, 2021
Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBDJohn M Errico, Haiyan Zhao, Rita E Chen, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young Do Kwon, Jason Gorman, et al.
Cell Reports. Medicine|March 23, 2021
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaquesAhmed O Hassan, Friederike Feldmann, Haiyan Zhao, et al.
Cell Reports. Medicine|January 31, 2026
An intranasal adenoviral-vectored vaccine protects against highly pathogenic avian influenza H5N1 in naive and antigen-experienced animalsBaoling Ying, Kelly Pyles, Tamarand L Darling, et al.
Pageof 9